Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents

European Journal of Pharmacology

Volumn 474, Issue 1, 2003, Pages 95-101

  Chaki, Shigeyuki ^a   Ogawa, Shin Ichi ^a   Toda, Yoshihisa ^a   Funakoshi, Takeo ^a   Okuyama, Shigeru ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anxiety; MCL0020; Melanocortin; Melanocortin MC4 receptor; MT II (Ac Nle4,Asp5,D Phe7,Lys10 MSH (4 10) NH2)

Indexed keywords

ALPHA INTERMEDIN; CYCLIC AMP; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; MCL 0020; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 4 RECEPTOR AGONIST; MELANOCORTIN 4 RECEPTOR ANTAGONIST; MT II; UNCLASSIFIED DRUG; AC D 2NAL ARG 2NAL NH2; AC-D-2NAL-ARG-2NAL-NH2; OLIGOPEPTIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BINDING AFFINITY; CELL STRAIN COS1; CONFLICT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; EXPLORATORY BEHAVIOR; FOOD INTAKE; IC 50; IMMOBILIZATION STRESS; LICKING; LIGHT; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; SWIMMING; TIME; ANIMAL; BINDING COMPETITION; CERCOPITHECUS; DRUG ANTAGONISM; DRUG POTENTIATION; EXERCISE; FEEDING BEHAVIOR; GENETIC TRANSFECTION; GROOMING; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; STRESS; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEEDING BEHAVIOR; GROOMING; HUMANS; MALE; MICE; MICE, INBRED ICR; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RESTRAINT, PHYSICAL; STRESS; SWIMMING; TRANSFECTION;

EID: 0142075366     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02033-8     Document Type: Article

References (31)

1. Adan R.A.H., Szklarczyk A.W., Oosterom J., Brakkee J.H., Nijenhuis W.A.J., Schaaper W.M.M., Meloen R.H., Gispen W.H. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooning behavior in the rat. Eur. J. Pharmacol. 378:1999;249-258.
2. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Chaki S., Hirota S., Funakoshi T., Suzuki Y., Suetake S., Okubo T., Ishii T., Nakazato A., Okuyama S. Anxiolytic-like and antidepressant-like activities of MCL0129, (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl) ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl] piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. J. Pharmacol. Exp. Ther. 304:2002;818-826.
4. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
5. Chhajlani V., Muceniece R., Wikberg J.E.S. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 195:1993;866-873.
6. Corda M.G., Orlandi M., Fratta W. Proconflict effect of ACTH1-24: interaction with benzodiazepines. Pharmacol. Biochem. Behav. 36:1990;631-634.
7. De Barioglio S.R., Lezcano N., Celis M.E. Alpha MSH-induced excessive grooming behavior involves a GABAergic mechanism. Peptides. 12:1991;203-205.
8. De Wied D., Jolles J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol. Rev. 62:1982;976-1059.
9. Dunn A.J., Green E.J., Isaacson R.L. Intracerebral adrenocorticotropic hormone mediates novelty-induced grooming in the rat. Science. 203:1979;281-283.
10. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
11. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz H., Northrop J.P., Ringold G.M., Danielsen M. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U. S. A. 84:1987;7413-7417.
12. File S.E., Clarke A. Intraventricular ACTH reduces social interaction in male rats. Pharmacol. Biochem. Behav. 12:1980;711-715.
13. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., Del Valle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268:1993;8246-8250.
14. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., Del Valle J., Yamada T. Molecular cloning, expression, and gene localization of a forth melanocortin receptor. J. Biol. Chem. 268:1993;15174-15179.
15. Gantz I., Shimoto Y., Konda Y., Miwa H., Dckinson C.J., Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200:1994;1214-1220.
16. Gonzalez M.I., Vaziri S., Wilson C.A. Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides. 17:1996;171-177.
17. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
18. Jonsson L., Skarphedinsson J.O., Skuladottir G.V., Atlason P.T., Eiriksdottir V.H., Franzson L., Schioth H.B. Melanocortin receptor agonist transiently increases oxygen consumption in rats. NeuroReport. 12:2001;3703-3708.
19. Kask A., Mutulis F., Muceniece R., Pahkla R., Mutule I., Wikberg J.E.S., Rago L., Schioth H.B. Discovery of a novel superpotent and selective melanocortine-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology. 139:1998;5006-5014.
20. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
21. Murphy M.T., Richards D.B., Lipton J.M. Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone. Science. 221:1983;192-193.
22. Okuyama S., Chaki S., Kawashima N., Suzuki Y., Ogawa S., Nakazato A., Kumagai T., Okubo T., Tomisawa K. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J. Pharmacol. Exp. Ther. 289:1999;926-935.
23. Panksepp J., Normansell L. Effects of ACTH(1-24) and ACTH/MSH(4-10) on isolation-induced distress vocalization in domestic chicks. Peptides. 11:1990;915-919.
24. Poggioli R., Vergoni A.V., Bertolini A. ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides. 7:1986;843-848.
25. Schioth H.B., Mutulis F., Muceniece R., Prusis P., Wikberg J.E.S. Discovery of novel melanocortin4 receptor selective MSH analogues. Br. J. Pharmacol. 124:1998;75-82.
26. Skuladottir G.V., Jonsson L., Skarphedinsson J.O., Mutulis F., Muceniece R., Raine A., Mutule I., Helgason J., Prusis P., Wikberg J.E.S., Schioth H.B. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br. J. Pharmacol. 126:1999;27-34.
27. Vergoni A.V., Bertolini A., Wikberg J.E.S., Scioth H.B. Selective melanocortin MC4 receptor blockage reduced immobilization stress-induced anorexia in rats. Eur. J. Pharmacol. 369:1999;11-15.
28. Vogel J.R., Beer B., Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia. 21:1971;1-7.
29. Von Frijtag J.C., Croiset G., Gispen W.H., Adan R.A.H., Wiegant V.M. The role of central melanocortin receptors in the activation of the hypothalamus-pituitary-adrenal axis and the induction of excessive grooming. Br. J. Pharmacol. 123:1998;1503-1508.
30. Vrinten D.H., Gispen W.H., Groen G.J., Adan R.A.H. Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats. J. Neurosci. 20:2000;8131-8137.
31. Vrinten D.H., Adan R.A.H., Groen G.J., Gispen W.H. Chronic blockade of melanocortin receptors alleviates allodynia in rats with neuropathic pain. Anesth. Analg. 93(6):2001;1572-1577.